Laser Pigmentation Treatment

“Laser pigmentation treatment” sounds as though pigmentation were one diagnosis and laser were one treatment.

Neither is true.

A small, sharply defined solar lentigo can be an excellent laser target. A broad area of melasma may look equally brown but behaves very differently. Post-inflammatory hyperpigmentation after acne has another biological history. Freckles have their own genetic and ultraviolet relationship. A blue-grey dermal pigment sits at a different depth from a superficial epidermal brown spot.

Even before treatment selection, there is another question that matters more than any wavelength: is the lesion definitely appropriate for cosmetic treatment?

This is why I do not begin with the laser.

I begin with the pigment: what produced it, where is it located, how reactive is the surrounding skin, and are we dealing with a benign cosmetic pigment problem at all?

Only after those questions are answered does the device become relevant.

Brown is an appearance, not a diagnosis

Melanin can become more visible for many reasons.

Ultraviolet exposure can produce discrete lentigines. Inflammation can leave pigment behind after acne, eczema, trauma or an aesthetic procedure. Melasma reflects a much more complex and recurrent pigmentary tendency. Freckles can intensify with light exposure while remaining a normal inherited feature.

These conditions may contain the same chromophore — melanin — but that does not make their biology identical.

This distinction is central to laser treatment because the laser can interact successfully with pigment and still fail clinically if the condition producing the pigment remains active.

The fact that a laser can see melanin does not mean every melanin problem should be treated with a laser.

Technology can target colour more precisely than the eye.

It still cannot replace the diagnosis that tells us whether targeting that colour is a good idea.

Before treating a spot, I want to know that it is a spot I should treat

A patient may arrive asking to remove one brown lesion that they have always assumed is a sunspot.

If that lesion is new, changing, irregular, bleeding, symptomatic or clinically atypical, aesthetic removal is not my first priority.

Some pigmented lesions require dermoscopic or dermatological assessment before any device changes their appearance.

The reason is simple.

A laser can make a lesion less visible. That is exactly what I do not want before a lesion that needed diagnosis has been properly evaluated.

Cosmetic treatment should follow diagnostic safety.

The patient’s confidence that something is “just pigmentation” does not establish what the lesion is.

Laser treatment works by matching light to a target

Many pigment lasers are designed around selective photothermolysis or related photoacoustic principles.

Melanin absorbs particular wavelengths of light. When energy is delivered with appropriate wavelength, pulse duration and fluence, pigment-containing structures can absorb enough energy to be disrupted while limiting injury to surrounding tissue.

The details matter.

Short nanosecond and picosecond pulses can create rapid pigment disruption. Other wavelengths may penetrate more or less deeply or interact differently with epidermal melanin.

This is why “laser” is not a meaningful treatment description by itself.

A 532-nm system, a 755-nm alexandrite platform and a 1064-nm Nd:YAG treatment do not interact with skin in exactly the same way.

The device has to be selected according to target depth, skin type and the biological behaviour of the pigment.

Wavelength is only one part of the dose

Patients often ask which laser is best for pigmentation.

I think that question places too much responsibility on wavelength alone.

Pulse duration changes the way energy is delivered. Fluence changes the energy density. Spot size influences penetration and energy distribution. Repetition rate and number of passes alter cumulative exposure.

Cooling and treatment technique also matter.

The same device can therefore produce very different biological effects depending on how it is used.

A laser name does not create precision.

Precision comes from matching the parameters to the pigment and to the skin carrying it.

Solar lentigines are among the clearest laser indications

A well-defined benign sunspot is conceptually straightforward.

There is a localised area containing excess pigment, and the treatment can be directed toward that pigment.

Clinical trials and systematic reviews show that several laser and light technologies can produce substantial improvement in solar lentigines.

This does not mean one wavelength wins in every patient.

A lesion on lighter untanned skin creates a different treatment environment from a similar-looking lesion in highly pigment-reactive skin. The location, colour and depth also influence device choice.

But when the diagnosis is clear, laser treatment can be one of the most efficient examples of mechanism matching in aesthetic dermatology.

There is a defined optical target and a technology specifically capable of interacting with it.

Freckles can respond, but the genetic tendency remains

Freckles often respond well to pigment-directed light or laser treatment.

That does not change the patient’s underlying tendency to produce them.

Ultraviolet exposure can make existing freckles darker and contribute to new visible lesions over time.

This means successful clearance is not immunity.

A patient can obtain an excellent cosmetic result and later develop recurrent or new pigmentation without the original treatment having failed.

I think this is important because recurrence should be explained through biology rather than used later as a reason to sell indefinite treatment packages.

Post-inflammatory pigmentation is where laser treatment can solve the problem or reproduce it

Post-inflammatory hyperpigmentation develops because inflammation has stimulated melanocytes and altered pigment distribution.

The acne lesion, dermatitis or injury may already be gone, but the pigment remains.

Laser and energy-based devices can improve selected PIH.

The paradox is that laser treatment itself creates inflammation.

If treatment is too aggressive for the patient’s skin, the intervention intended to remove PIH can produce a new episode of PIH.

This is particularly relevant in darker and more pigment-reactive skin types.

For me, that changes the threshold completely.

The question is not merely whether the laser is capable of disrupting the remaining pigment. It is whether we can do so with a lower inflammatory signal than the skin is likely to answer with new melanogenesis.

The original inflammatory disease should be controlled before chasing its pigment

A patient with active acne and post-acne pigmentation can easily become trapped in the wrong sequence.

They focus on the brown marks because those marks remain visible longer than individual pimples.

But if inflammatory acne continues producing new lesions, new pigmentation is still being generated while we are trying to remove the old pigmentation.

The same principle applies to eczema and recurrent irritation.

Controlling the trigger first often makes the pigment plan both safer and more efficient.

I do not want to use increasingly sophisticated lasers to chase a colour that an untreated disease continues recreating.

Melasma is the condition in which “more pigment treatment” most easily becomes worse pigment management

Melasma can improve with selected laser strategies.

That is true.

Recent randomised-trial meta-analyses continue to show measurable reductions in melasma severity after several laser approaches.

But that finding needs context.

Melasma is chronic, recurrent and biologically reactive. Ultraviolet exposure, visible light, hormones, genetics and inflammatory signals can influence it. Recurrence remains common, and post-treatment hyperpigmentation is a meaningful risk.

Some recent comparative evidence even shows established topical combination therapy outperforming certain picosecond-laser protocols while producing less PIH.

This is why I do not interpret “laser can improve melasma” as “melasma should be lasered”.

A treatment can be effective and still not be the first or best treatment for a particular patient.

In melasma, photoprotection, topical therapy and control of the pigmentary tendency often remain the foundation. Laser may become an adjunct in selected resistant cases rather than the centre of every plan.

Repeated low-fluence laser treatment is not harmless simply because each session is gentle

Low-fluence 1064-nm Q-switched Nd:YAG treatment has been widely used in so-called laser toning protocols for melasma and diffuse pigmentation.

The intention is to affect pigment gradually while reducing the inflammatory burden of stronger treatment.

That can work in selected patients.

But repeated treatments have also been associated with problems such as mottled hypopigmentation and paradoxical pigmentary change.

This is a useful reminder that cumulative biological exposure matters.

A treatment can be individually mild yet become excessive through repetition.

I therefore do not regard “low energy” as permission for indefinite sessions.

The response and the skin’s pigment stability still need to be reassessed.

Picosecond does not mean pigment complications have been engineered away

Picosecond technology delivers extremely short pulses and can fragment pigment with a strong photoacoustic component.

This has created useful treatment possibilities, including for selected benign pigmentation and tattoos.

Shorter pulse duration can reduce some unwanted thermal spread compared with longer pulses in certain contexts.

But the word picosecond should not become a safety guarantee.

The surrounding skin still contains melanin. Inflammation can still occur. PIH can still develop, particularly in melasma and pigment-reactive patients.

Recent systematic evidence reinforces this point.

A more technologically precise pulse is useful.

It does not make patient selection obsolete.

Skin tone is part of the treatment physics

When a laser is designed to target melanin, the background melanin in normal epidermis matters.

The more competing melanin there is, the narrower the therapeutic window may become for certain wavelengths and applications.

This does not mean darker skin cannot be treated.

It means the treatment strategy has to change.

Wavelength selection, fluence, pulse duration, spot size, cooling, treatment interval and the decision to treat at all may need to become more conservative.

The patient’s previous history of PIH also matters because it tells us something about how strongly their melanocytes respond to inflammation.

Skin colour is not a demographic variable in pigment laser treatment.

It is part of the optical environment through which the laser has to work.

A tan changes the treatment even if the patient’s natural skin type has not changed

A recent tan means additional epidermal melanin is present.

That additional melanin competes for the same light energy we may be trying to direct toward an unwanted pigment lesion.

This can reduce selectivity and increase the risk of epidermal injury, burns and post-inflammatory pigment change.

I therefore treat tanning history as part of treatment planning, not simply a lifestyle question on the intake form.

Waiting for a tan to resolve can be a clinical decision.

There is no advantage in performing an elective pigment treatment during a period in which the optics of the skin are working against us.

Test spots can reduce uncertainty, but they do not remove it

In selected high-risk pigment situations, a test spot can provide useful information about how the lesion and surrounding skin respond to a particular setting.

That can be helpful before committing to a larger field of treatment.

But a test spot does not guarantee that an entire face will respond identically.

Different facial areas have different thicknesses, pigment concentrations and exposure histories.

It is an additional piece of information rather than an insurance policy.

I use it when it genuinely answers a question that remains uncertain after examination.

The immediate whitening or darkening of pigment is an endpoint, not a performance spectacle

Different pigment lasers can create different immediate visible responses.

A lesion may transiently whiten, grey, darken or develop another characteristic endpoint depending on the technology and target.

These reactions can help guide treatment.

They should not become a competition to produce the most dramatic visible change.

Once the desired tissue endpoint has been reached, additional passes can simply increase inflammation.

The purpose of the immediate response is to inform dosing.

It is not evidence that a stronger treatment was purchased.

Brown spots can look worse before they look better

After pigment-directed treatment, some lesions become temporarily darker.

The treated pigment can then fragment, crust lightly or gradually clear as the skin processes the damaged material.

This expected evolution should be explained beforehand.

Otherwise a patient may see darker pigment several days after treatment and assume the condition has been worsened.

At the same time, excessive blistering, prolonged inflammation or new diffuse hyperpigmentation is a different situation.

Expected pigment processing and unintended tissue injury should not be blurred into one reassurance.

The lesion may disappear while the tendency that created it remains

This is especially important in photoaging.

A laser can remove a visible solar lentigo very successfully.

It cannot undo the patient’s cumulative ultraviolet exposure or prevent future lesions from developing elsewhere.

Photoprotection therefore becomes part of the long-term result.

The same principle applies even more strongly to melasma and PIH.

Laser treatment can change visible pigment.

It does not necessarily remove the biological trigger that told the melanocyte to produce that pigment.

Maintenance should not mean routinely lasering normal skin

A patient who previously developed sunspots may return later with new lesions.

Those lesions can be assessed and treated if appropriate.

That is different from scheduling a full-face pigment laser automatically every year regardless of what is present.

I want maintenance to remain lesion- and mechanism-driven.

If the skin is clear, another treatment may add very little.

If the pigmentation pattern has changed, the diagnosis may also have changed.

A historical success with one laser does not permanently assign every future brown mark to the same device.

Laser and topical treatment should not be forced into a competition

Topical therapy can influence pigment production continuously over time.

Laser can remove or disrupt selected pigment more rapidly.

These are different strengths.

In conditions such as melasma and PIH, the combination of controlling melanogenesis and selectively treating residual pigment can sometimes be rational.

But recent evidence also shows that combining laser with topical therapy can increase adverse events in some melasma protocols.

Combination treatment therefore needs the same discipline as monotherapy.

More mechanisms can create more benefit.

They can also create more inflammation.

Laser pigmentation treatment is not skin resurfacing

The two categories overlap technologically in some devices, but the clinical objective is different.

A pigment laser is primarily selected because of how its wavelength and pulse interact with melanin or another chromophore.

A resurfacing laser is primarily selected to create controlled epidermal and dermal injury for tissue renewal and remodelling.

If the patient’s problem is one isolated lentigo, full resurfacing may be excessive.

If the problem is broad textural photodamage and scarring, removing individual pigment spots may leave the main structural concern untouched.

I want the treatment category to remain tied to the dominant problem rather than to the fact that both machines happen to use light.

What a good laser pigmentation result means to me

For a discrete benign lesion, the goal may be substantial clearing with minimal disruption to surrounding skin.

For diffuse pigmentation, I look for improved uniformity rather than unnaturally pigment-free skin.

For melasma, success may mean meaningful reduction and better long-term control rather than permanent disappearance.

And in every case, I judge the result partly by what did not happen.

The surrounding skin should not develop a larger field of PIH. Normal pigment should be preserved. A benign cosmetic problem should not be exchanged for persistent hypopigmentation or scarring.

The safest pigment treatment is selective enough that the target changes more than the patient carrying it.

When laser pigmentation treatment makes sense to me

I am most comfortable recommending laser when the pigment diagnosis is clear, the target is biologically suitable for light treatment and the patient’s skin provides a reasonable therapeutic window.

Discrete benign lentigines and selected freckles are among the most straightforward indications. Certain PIH and resistant pigment conditions can also be considered with greater caution.

I become more conservative when melasma is unstable, the patient is recently tanned, there is a strong history of PIH, the lesion has not been medically characterised or the expected improvement is too small to justify the pigment risk.

Laser technology can be remarkably precise.

But the most precise treatment decision still happens before the laser is switched on.

If I have not defined the pigment correctly, choosing a sophisticated wavelength only makes the wrong treatment more sophisticated.

Frequently asked questions

What pigmentation can laser treatment improve?

Lasers can be useful for selected benign solar lentigines, freckles, some post-inflammatory pigmentation and other appropriately diagnosed pigment conditions. The correct device and expected response differ substantially between diagnoses.

What is the best laser for dark spots?

There is no universal best laser. Wavelength, pulse duration and treatment settings need to match the pigment depth, skin type and diagnosis. A device suitable for a discrete sunspot may not be the best strategy for melasma.

Can laser remove sunspots completely?

Selected benign lentigines can clear very well, sometimes after relatively limited treatment. New sunspots can still develop later because laser does not remove the underlying history or future effects of ultraviolet exposure.

Can laser treat melasma?

It can improve melasma in selected patients, and recent meta-analyses show measurable benefit. However, recurrence and post-inflammatory pigmentation remain important limitations, so laser is usually considered within a broader management strategy rather than as a guaranteed cure.

Can laser make melasma worse?

Yes. Excessive heat or inflammation can exacerbate pigmentation in susceptible skin. This is one reason patient selection and conservative parameters are particularly important in melasma.

Can laser treat post-acne dark marks?

Selected post-inflammatory hyperpigmentation can improve with laser or energy-based treatment. Active acne should still be controlled because ongoing inflammation continues creating new pigment.

Is laser safe for darker skin tones?

It can be appropriate, but higher background melanin changes the treatment margin and the risk of post-inflammatory pigment change. Device and parameter selection need to reflect the patient’s skin rather than use one protocol for every complexion.

Why do my spots look darker after laser?

Some appropriately treated lesions temporarily darken before clearing as damaged pigment is processed. This expected response should be distinguished from diffuse worsening pigmentation, blistering or other signs of excessive tissue injury.

Are picosecond lasers safer for pigmentation?

The very short pulse duration offers useful pigment-fragmentation characteristics, but picosecond technology does not eliminate PIH or make every pigment disorder appropriate for laser treatment.

What is laser toning?

The term commonly refers to repeated low-fluence treatment, often with 1064-nm Q-switched Nd:YAG, particularly for diffuse pigmentation or melasma. It can help selected patients, but excessive repetition has been associated with pigmentary complications including mottled hypopigmentation.

How many sessions will I need?

The number depends on the diagnosis. A discrete lentigo and chronic melasma do not belong on the same treatment schedule. I prefer to reassess the remaining target after each appropriate treatment phase rather than promise one universal package.

Can the pigmentation return?

Yes. Recurrence depends strongly on the condition. Melasma and freckles have underlying biological tendencies, while new solar lentigines can develop with continued ultraviolet exposure.

When would you recommend no pigment laser?

I would not proceed when the lesion requires diagnostic evaluation first, the skin is recently tanned, pigment instability creates an unfavourable risk, or the likely cosmetic improvement is too small to justify the possibility of PIH or other complications.